Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sian E Harding

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2002
High-resolution scanning patch-clamp: new insights into cell functionYuchun Gu, Julia Gorelik, Hilmar A Spohr, et al.
Stem Cell Research & Therapy|October 1, 2017
Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cellsVictor G Martinez, Imelda Ontoria-Oviedo, Carolina P Ricardo, et al.
Circulation|May 30, 2002
Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heartHaibin Gong, Hong Sun, Walter J Koch, et al.
European Heart Journal|July 23, 2003
Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapyCesare M N Terracciano, Sian E Harding, Dawn Adamson, et al.
Cardiovascular Research|March 29, 2013
Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia: replyMarkus B Sikkel, Thomas P Collins, Christina Rowlands, et al.
Cardiovascular Research|January 22, 2013
Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium currentMarkus B Sikkel, Thomas P Collins, Christina Rowlands, et al.
Cardiovascular Research|October 11, 2017
Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studiesMarkus B Sikkel, Darrel P Francis, James Howard, et al.
Stem Cells (Dayton, Ohio)|September 10, 2015
Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?Elodie Gouadon, Thomas Moore-Morris, Nicoline W Smit, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2009
Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heartAlexander R Lyon, Ken T MacLeod, Yanjun Zhang, et al.
Clinical Chemistry|April 6, 2017
Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact MyocardiumJack Marjot, Thomas E Kaier, Eva D Martin, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2002
High-resolution scanning patch-clamp: new insights into cell functionYuchun Gu, Julia Gorelik, Hilmar A Spohr, et al.
Stem Cell Research & Therapy|October 1, 2017
Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cellsVictor G Martinez, Imelda Ontoria-Oviedo, Carolina P Ricardo, et al.
Circulation|May 30, 2002
Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heartHaibin Gong, Hong Sun, Walter J Koch, et al.
European Heart Journal|July 23, 2003
Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapyCesare M N Terracciano, Sian E Harding, Dawn Adamson, et al.
Cardiovascular Research|March 29, 2013
Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia: replyMarkus B Sikkel, Thomas P Collins, Christina Rowlands, et al.
Cardiovascular Research|January 22, 2013
Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium currentMarkus B Sikkel, Thomas P Collins, Christina Rowlands, et al.
Cardiovascular Research|October 11, 2017
Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studiesMarkus B Sikkel, Darrel P Francis, James Howard, et al.
Stem Cells (Dayton, Ohio)|September 10, 2015
Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?Elodie Gouadon, Thomas Moore-Morris, Nicoline W Smit, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2009
Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heartAlexander R Lyon, Ken T MacLeod, Yanjun Zhang, et al.
Clinical Chemistry|April 6, 2017
Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact MyocardiumJack Marjot, Thomas E Kaier, Eva D Martin, et al.
Pageof 15